The Notch intracellular domain integrates signals from Wnt, Hedgehog, TGFβ/BMP and hypoxia pathways

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1863, Issue 2, 2016, Pages 303-313

  Borggrefe, Tilman ^a   Lauth, Matthias ^b   Zwijsen, An ^c   Huylebroeck, Danny ^d   Oswald, Franz ^e   Giaimo, Benedetto Daniele ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Hydroxylation; Methylation; Notch signal transduction; Post translational modifications; Signaling crosstalk; Transcription factor Hes1

Indexed keywords

BONE MORPHOGENETIC PROTEIN; LIGAND; NOTCH RECEPTOR; NOTCH2 RECEPTOR; NOTCH3 RECEPTOR; NOTCH4 RECEPTOR; RECEPTOR; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

CARCINOGENESIS; GENE EXPRESSION REGULATION; GENE TARGETING; HYDROXYLATION; HYPOXIA; PRIORITY JOURNAL; PROTEIN ACETYLATION; PROTEIN DOMAIN; PROTEIN METHYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STABILITY; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION; ANIMAL; ANOXIA; BIOLOGICAL MODEL; HUMAN; METABOLISM;

ANIMALS; ANOXIA; BONE MORPHOGENETIC PROTEINS; HEDGEHOG PROTEINS; HUMANS; MODELS, BIOLOGICAL; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEINS;

EID: 84949293913     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2015.11.020     Document Type: Review

References (187)

1. Artavanis-Tsakonas S., Rand M.D., Lake R.J. Notch signaling: cell fate control and signal integration in development. Science 1999, 284:770-776.
2. Koch U., Lehal R., Radtke F. Stem cells living with a Notch. Development 2013, 140:689-704.
3. Hori K., Sen A., Artavanis-Tsakonas S. Notch signaling at a glance. J. Cell Sci. 2013, 126:2135-2140.
4. Brou C., et al. A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol. Cell 2000, 5:207-216.
5. Mumm J.S., et al. A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. Mol. Cell 2000, 5:197-206.
6. Fortini M.E. Gamma-secretase-mediated proteolysis in cell-surface-receptor signalling. Nat. Rev. Mol. Cell Biol. 2002, 3:673-684.
7. Wu L., et al. MAML1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptors. Nat. Genet. 2000, 26:484-489.
8. Nam Y., Weng A.P., Aster J.C., Blacklow S.C. Structural requirements for assembly of the CSL.Intracellular Notch1.Mastermind-like 1 transcriptional activation complex. J. Biol. Chem. 2003, 278:21232-21239.
9. Nam Y., Sliz P., Song L., Aster J.C., Blacklow S.C. Structural basis for cooperativity in recruitment of MAML coactivators to Notch transcription complexes. Cell 2006, 124:973-983.
10. Wilson J.J., Kovall R.A. Crystal structure of the CSL-Notch-Mastermind ternary complex bound to DNA. Cell 2006, 124:985-996.
11. Fryer C.J., Lamar E., Turbachova I., Kintner C., Jones K.A. Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex. Genes Dev. 2002, 16:1397-1411.
12. Hansson M.L., et al. The transcriptional coactivator MAML1 regulates p300 autoacetylation and HAT activity. Nucleic Acids Res. 2009, 37:2996-3006.
13. Saint Just Ribeiro M., Hansson M.L., Wallberg A.E. A proline repeat domain in the Notch co-activator MAML1 is important for the p300-mediated acetylation of MAML1. Biochem. J. 2007, 404:289-298.
14. Popko-Scibor A.E., Lindberg M.J., Hansson M.L., Holmlund T., Wallberg A.E. Ubiquitination of Notch1 is regulated by MAML1-mediated p300 acetylation of Notch1. Biochem. Biophys. Res. Commun. 2011, 416:300-306.
15. Jung C., Mittler G., Oswald F., Borggrefe T. RNA helicase Ddx5 and the noncoding RNA SRA act as coactivators in the Notch signaling pathway. Biochim. Biophys. Acta 2013, 1833:1180-1189.
16. Lin S., et al. DDX5 is a positive regulator of oncogenic NOTCH1 signaling in T cell acute lymphoblastic leukemia. Oncogene 2013, 32:4845-4853.
17. Weng A.P., et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004, 306:269-271.
18. Kurooka H., Kuroda K., Honjo T. Roles of the ankyrin repeats and C-terminal region of the mouse notch1 intracellular region. Nucleic Acids Res. 1998, 26:5448-5455.
19. Puente X.S., et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 2011, 475:101-105.
20. Stephens P.J., et al. Whole exome sequencing of adenoid cystic carcinoma. J. Clin. Invest. 2013, 123:2965-2968.
21. Fryer C.J., White J.B., Jones K.A. Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover. Mol. Cell 2004, 16:509-520.
22. Gupta-Rossi N., et al. Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor. J. Biol. Chem. 2001, 276:34371-34378.
23. Oberg C., et al. The Notch intracellular domain is ubiquitinated and negatively regulated by the mammalian Sel-10 homolog. J. Biol. Chem. 2001, 276:35847-35853.
24. Wu G., et al. SEL-10 is an inhibitor of Notch signaling that targets Notch for ubiquitin-mediated protein degradation. Mol. Cell. Biol. 2001, 21:7403-7415.
25. O'Neil J., et al. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J. Exp. Med. 2007, 204:1813-1824.
26. Thompson B.J., et al. Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7. J. Exp. Med. 2008, 205:1395-1408.
27. Li N., et al. Cyclin C is a haploinsufficient tumour suppressor. Nat. Cell Biol. 2014, 16:1080-1091.
28. Thompson B.J., et al. The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia. J. Exp. Med. 2007, 204:1825-1835.
29. Kumar V., et al. Notch and NF-κB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia. Leukemia 2014, 28:2324-2335.
30. Chiang M.Y., et al. Identification of a conserved negative regulatory sequence that influences the leukemogenic activity of NOTCH1. Mol. Cell. Biol. 2006, 26:6261-6271.
31. Ishitani T., et al. Nemo-like kinase suppresses Notch signalling by interfering with formation of the Notch active transcriptional complex. Nat. Cell Biol. 2010, 12:278-285.
32. Fernandez-Martinez J., et al. Attenuation of Notch signalling by the Down-syndrome-associated kinase DYRK1A. J. Cell Sci. 2009, 122:1574-1583.
33. Han X., Ju J.H., Shin I. Glycogen synthase kinase 3-beta phosphorylates novel S/T-P-S/T domains in Notch1 intracellular domain and induces its nuclear localization. Biochem. Biophys. Res. Commun. 2012, 423:282-288.
34. Ranganathan P., et al. Hierarchical phosphorylation within the ankyrin repeat domain defines a phosphoregulatory loop that regulates Notch transcriptional activity. J. Biol. Chem. 2011, 286:28844-28857.
35. Sjoqvist M., et al. PKCzeta regulates Notch receptor routing and activity in a Notch signaling-dependent manner. Cell Res. 2014, 24:433-450.
36. Ingles-Esteve J., Espinosa L., Milner L.A., Caelles C., Bigas A. Phosphorylation of Ser2078 modulates the Notch2 function in 32D cell differentiation. J. Biol. Chem. 2001, 276:44873-44880.
37. Espinosa L., Ingles-Esteve J., Aguilera C., Bigas A. Phosphorylation by glycogen synthase kinase-3 beta down-regulates Notch activity, a link for Notch and Wnt pathways. J. Biol. Chem. 2003, 278:32227-32235.
38. Guarani V., et al. Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase. Nature 2011, 473:234-238.
39. Palermo R., et al. Acetylation controls Notch3 stability and function in T-cell leukemia. Oncogene 2012, 31:3807-3817.
40. Coleman M.L., et al. Asparaginyl hydroxylation of the Notch ankyrin repeat domain by factor inhibiting hypoxia-inducible factor. J. Biol. Chem. 2007, 282:24027-24038.
41. Zheng X., et al. Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:3368-3373.
42. Wilkins S.E., et al. Differences in hydroxylation and binding of Notch and HIF-1alpha demonstrate substrate selectivity for factor inhibiting HIF-1 (FIH-1). Int. J. Biochem. Cell Biol. 2009, 41:1563-1571.
43. Rustighi A., et al. The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer. Nat. Cell Biol. 2009, 11:133-142.
44. Hein K., et al. Site-specific methylation of Notch1 controls the amplitude and duration of the Notch1 response. Sci. Signal. 2015, 8:ra30.
45. Kim D., et al. Ubiquitination-dependent CARM1 degradation facilitates Notch1-mediated podocyte apoptosis in diabetic nephropathy. Cell. Signal. 2014, 26:1774-1782.
46. Qiu L., et al. Recognition and ubiquitination of Notch by Itch, a hect-type E3 ubiquitin ligase. J. Biol. Chem. 2000, 275:35734-35737.
47. McGill M.A., McGlade C.J. Mammalian numb proteins promote Notch1 receptor ubiquitination and degradation of the Notch1 intracellular domain. J. Biol. Chem. 2003, 278:23196-23203.
48. McGill M.A., Dho S.E., Weinmaster G., McGlade C.J. Numb regulates post-endocytic trafficking and degradation of Notch1. J. Biol. Chem. 2009, 284:26427-26438.
49. Puca L., Chastagner P., Meas-Yedid V., Israel A., Brou C. Alpha-arrestin 1 (ARRDC1) and beta-arrestins cooperate to mediate Notch degradation in mammals. J. Cell Sci. 2013, 126:4457-4468.
50. Sun Y., et al. Trp53 regulates Notch 4 signaling through Mdm2. J. Cell Sci. 2011, 124:1067-1076.
51. Pettersson S., et al. Non-degradative ubiquitination of the Notch1 receptor by the E3 ligase MDM2 activates the Notch signalling pathway. Biochem. J. 2013, 450:523-536.
52. Nam Y., Sliz P., Pear W.S., Aster J.C., Blacklow S.C. Cooperative assembly of higher-order Notch complexes functions as a switch to induce transcription. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:2103-2108.
53. Hass M.R., et al. SpDamID: marking DNA bound by protein complexes identifies Notch-dimer responsive enhancers. Mol. Cell 2015, 59:685-697.
54. Liu H., et al. Notch dimerization is required for leukemogenesis and T-cell development. Genes Dev. 2010, 24:2395-2407.
55. Holland J.D., Klaus A., Garratt A.N., Birchmeier W. Wnt signaling in stem and cancer stem cells. Curr. Opin. Cell Biol. 2013, 25:254-264.
56. Ma J., Wang R. Fang, X. & Sun, Z. Beta-catenin/TCF-1 pathway in T cell development and differentiation. J. NeuroImmune Pharmacol. 2012, 7:750-762.
57. Kim W., Kim M., Jho E.H. Wnt/beta-catenin signalling: from plasma membrane to nucleus. Biochem. J. 2013, 450:9-21.
58. Nishisho I., et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991, 253:665-669.
59. Liu W., et al. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat. Genet. 2000, 26:146-147.
60. Minde D.P., Anvarian Z., Rudiger S.G., Maurice M.M. Messing up disorder: how do missense mutations in the tumor suppressor protein APC lead to cancer?. Mol. Cancer 2011, 10:101.
61. Morin P.J., et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997, 275:1787-1790.
62. Collu G.M., Hidalgo-Sastre A., Brennan K. Wnt-Notch signalling crosstalk in development and disease. Cell. Mol. Life Sci. 2014, 71:3553-3567.
63. Klein T., Arias A.M. The vestigial gene product provides a molecular context for the interpretation of signals during the development of the wing in Drosophila. Development 1999, 126:913-925.
64. Galceran J., Sustmann C., Hsu S.C., Folberth S., Grosschedl R. LEF1-mediated regulation of Delta-like1 links Wnt and Notch signaling in somitogenesis. Genes Dev. 2004, 18:2718-2723.
65. Issack P.S., Ziff E.B. Genetic elements regulating HES-1 induction in Wnt-1-transformed PC12 cells. Cell Growth Differ. 1998, 9:827-836.
66. Shimizu T., et al. Stabilized beta-catenin functions through TCF/LEF proteins and the Notch/RBP-Jkappa complex to promote proliferation and suppress differentiation of neural precursor cells. Mol. Cell. Biol. 2008, 28:7427-7441.
67. Li B., et al. Interaction of Wnt/beta-catenin and notch signaling in the early stage of cardiac differentiation of P19CL6 cells. J. Cell. Biochem. 2012, 113:629-639.
68. Jin Y.H., et al. Beta-catenin modulates the level and transcriptional activity of Notch1/NICD through its direct interaction. Biochim. Biophys. Acta 2009, 1793:290-299.
69. Yamamizu K., et al. Convergence of Notch and beta-catenin signaling induces arterial fate in vascular progenitors. J. Cell Biol. 2010, 189:325-338.
70. Foltz D.R., Santiago M.C., Berechid B.E., Nye J.S. Glycogen synthase kinase-3beta modulates Notch signaling and stability. Curr. Biol. 2002, 12:1006-1011.
71. Hayward P., et al. Notch modulates Wnt signalling by associating with Armadillo/beta-catenin and regulating its transcriptional activity. Development 2005, 132:1819-1830.
72. Sanders P.G., et al. Ligand-independent traffic of Notch buffers activated Armadillo in Drosophila. PLoS Biol. 2009, 7.
73. Acosta H., Lopez S.L., Revinski D.R., Carrasco A.E. Notch destabilises maternal beta-catenin and restricts dorsal-anterior development in Xenopus. Development 2011, 138:2567-2579.
74. Kwon C., et al. Notch post-translationally regulates beta-catenin protein in stem and progenitor cells. Nat. Cell Biol. 2011, 13:1244-1251.
75. 2+ signaling pathway: a brief overview. Acta Biochim. Biophys. Sin. (Shanghai) 2011, 43:745-756.
76. Ann E.J., et al. Wnt5a controls Notch1 signaling through CaMKII-mediated degradation of the SMRT corepressor protein. J. Biol. Chem. 2012, 287:36814-36829.
77. Germar K., et al. T-cell factor 1 is a gatekeeper for T-cell specification in response to Notch signaling. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:20060-20065.
78. Wang H., et al. Genome-wide analysis reveals conserved and divergent features of Notch1/RBPJ binding in human and murine T-lymphoblastic leukemia cells. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:14908-14913.
79. Zhou J., Cheng P., Youn J.I., Cotter M.J., Gabrilovich D.I. Notch and wingless signaling cooperate in regulation of dendritic cell differentiation. Immunity 2009, 30:845-859.
80. Yun T.J., Bevan M.J. Notch-regulated ankyrin-repeat protein inhibits Notch1 signaling: multiple Notch1 signaling pathways involved in T cell development. J. Immunol. 2003, 170:5834-5841.
81. Ishitani T., Matsumoto K., Chitnis A.B., Itoh M. Nrarp functions to modulate neural-crest-cell differentiation by regulating LEF1 protein stability. Nat. Cell Biol. 2005, 7:1106-1112.
82. Phng L.K., et al. Nrarp coordinates endothelial Notch and Wnt signaling to control vessel density in angiogenesis. Dev. Cell 2009, 16:70-82.
83. Ungerback J., Elander N., Grunberg J., Sigvardsson M., Soderkvist P. The Notch-2 gene is regulated by Wnt signaling in cultured colorectal cancer cells. PLoS One 2011, 6.
84. Chen X., et al. Jagged1 expression regulated by Notch3 and Wnt/beta-catenin signaling pathways in ovarian cancer. Oncotarget 2010, 1:210-218.
85. Collu G.M., et al. Dishevelled limits Notch signalling through inhibition of CSL. Development 2012, 139:4405-4415.
86. Munoz-Descalzo S., et al. Wingless modulates the ligand independent traffic of Notch through Dishevelled. Fly (Austin) 2010, 4:182-193.
87. Capilla A., et al. Planar cell polarity controls directional Notch signaling in the Drosophila leg. Development 2012, 139:2584-2593.
88. Lum L., Beachy P.A. The Hedgehog response network: sensors, switches, and routers. Science 2004, 304:1755-1759.
89. Petrova R., Joyner A.L. Roles for Hedgehog signaling in adult organ homeostasis and repair. Development 2014, 141:3445-3457.
90. Robbins D.J., Fei D.L., Riobo N.A. The Hedgehog signal transduction network. Sci. Signal. 2012, 5:re6.
91. Briscoe J., Therond P.P. The mechanisms of Hedgehog signalling and its roles in development and disease. Nat. Rev. Mol. Cell Biol. 2013, 14:416-429.
92. Ingram W.J., McCue K.I., Tran T.H., Hallahan A.R., Wainwright B.J. Sonic Hedgehog regulates Hes1 through a novel mechanism that is independent of canonical Notch pathway signalling. Oncogene 2008, 27:1489-1500.
93. Wall D.S., et al. Progenitor cell proliferation in the retina is dependent on Notch-independent sonic hedgehog/Hes1 activity. J. Cell Biol. 2009, 184:101-112.
94. Stecca B., Ruiz i Altaba A. A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers. EMBO J. 2009, 28:663-676.
95. Takanaga H., et al. Gli2 is a novel regulator of sox2 expression in telencephalic neuroepithelial cells. Stem Cells 2009, 27:165-174.
96. Schreck K.C., et al. The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance. Clin. Cancer Res. 2010, 16:6060-6070.
97. Steg A.D., et al. Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer. Clin. Cancer Res. 2011, 17:5674-5685.
98. Androutsellis-Theotokis A., et al. Notch signalling regulates stem cell numbers in vitro and in vivo. Nature 2006, 442:823-826.
99. Kong J.H., et al. Notch activity modulates the responsiveness of neural progenitors to sonic hedgehog signaling. Dev. Cell 2015, 33:373-387.
100. Stasiulewicz M., et al. A conserved role for Notch signaling in priming the cellular response to Shh through ciliary localisation of the key Shh transducer Smo. Development 2015, 142:2291-2303.
101. Ezratty E.J., et al. A role for the primary cilium in Notch signaling and epidermal differentiation during skin development. Cell 2011, 145:1129-1141.
102. Lopes S.S., et al. Notch signalling regulates left-right asymmetry through ciliary length control. Development 2010, 137:3625-3632.
103. Ulasov I.V., Nandi S., Dey M., Sonabend A.M., Lesniak M.S. Inhibition of sonic hedgehog and Notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy. Mol. Med. 2011, 17:103-112.
104. Domingo-Domenech J., et al. Suppression of acquired docetaxel resistance in prostate cancer through depletion of Notch- and hedgehog-dependent tumor-initiating cells. Cancer Cell 2012, 22:373-388.
105. Okuhashi Y., Itoh M., Nara N., Tohda S. Effects of combination of Notch inhibitor plus hedgehog inhibitor or Wnt inhibitor on growth of leukemia cells. Anticancer Res. 2011, 31:893-896.
106. Da Ros V.G., Gutierrez-Perez I., Ferres-Marco D., Dominguez M. Dampening the signals transduced through hedgehog via microRNA miR-7 facilitates Notch-induced tumourigenesis. PLoS Biol. 2013, 11.
107. Lisy K., Peet D.J. Turn me on: regulating HIF transcriptional activity. Cell Death Differ. 2008, 15:642-649.
108. Hashimoto T., Shibasaki F. Hypoxia-inducible factor as an angiogenic master switch. Front. Pediatr. 2015, 3:33.
109. Mailhos C., et al. Delta4, an endothelial specific Notch ligand expressed at sites of physiological and tumor angiogenesis. Differentiation 2001, 69:135-144.
110. Patel N.S., et al. Up-regulation of Delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. Cancer Res. 2005, 65:8690-8697.
111. Diez H., et al. Hypoxia-mediated activation of Dll4-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate. Exp. Cell Res. 2007, 313:1-9.
112. Gustafsson M.V., et al. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev. Cell 2005, 9:617-628.
113. Kiriakidis S., et al. Factor-inhibiting HIF-1 (FIH-1) is required for human vascular endothelial cell survival. FASEB J. 2015, 29:2814-2827.
114. Villa J.C., et al. Nontranscriptional role of Hif-1alpha in activation of gamma-secretase and Notch signaling in breast cancer. Cell Rep. 2014, 8:1077-1092.
115. Phng L.K., Gerhardt H. Angiogenesis: a team effort coordinated by Notch. Dev. Cell 2009, 16:196-208.
116. Krebs L.T., et al. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 2000, 14:1343-1352.
117. Xue Y., et al. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum. Mol. Genet. 1999, 8:723-730.
118. Gridley T. Notch signaling in vascular development and physiology. Development 2007, 134:2709-2718.
119. Funahashi Y., et al. Notch regulates the angiogenic response via induction of VEGFR-1. J. Angiogenes. Res. 2010, 2:3.
120. Benedito R., et al. Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling. Nature 2012, 484:110-114.
121. Chen J., Imanaka N., Griffin J.D. Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion. Br. J. Cancer 2010, 102:351-360.
122. Ishida T., Hijioka H., Kume K., Miyawaki A., Nakamura N. Notch signaling induces EMT in OSCC cell lines in a hypoxic environment. Oncol. Lett. 2013, 6:1201-1206.
123. Sahlgren C., Gustafsson M.V., Jin S., Poellinger L., Lendahl U. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:6392-6397.
124. Danza G., et al. Notch3 is activated by chronic hypoxia and contributes to the progression of human prostate cancer. Int. J. Cancer 2013, 133:2577-2586.
125. Asnaghi L., et al. Hypoxia promotes uveal melanoma invasion through enhanced Notch and MAPK activation. PLoS One 2014, 9.
126. Qiang L., et al. HIF-1alpha is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway. Cell Death Differ. 2012, 19:284-294.
127. Hu Y.Y., et al. Hif-1alpha and Hif-2alpha differentially regulate Notch signaling through competitive interaction with the intracellular domain of Notch receptors in glioma stem cells. Cancer Lett. 2014, 349:67-76.
128. Kurpinski K., et al. Transforming growth factor-beta and Notch signaling mediate stem cell differentiation into smooth muscle cells. Stem Cells 2010, 28:734-742.
129. Kennard S., Liu H., Lilly B. Transforming growth factor-beta (TGF-1) down-regulates Notch3 in fibroblasts to promote smooth muscle gene expression. J. Biol. Chem. 2008, 283:1324-1333.
130. Morikawa M., et al. ChIP-seq reveals cell type-specific binding patterns of BMP-specific Smads and a novel binding motif. Nucleic Acids Res. 2011, 39:8712-8727.
131. Benedito R., et al. The Notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell 2009, 137:1124-1135.
132. Itoh F., et al. Synergy and antagonism between Notch and BMP receptor signaling pathways in endothelial cells. EMBO J. 2004, 23:541-551.
133. Moya I.M., et al. Stalk cell phenotype depends on integration of Notch and Smad1/5 signaling cascades. Dev. Cell 2012, 22:501-514.
134. Ricard N., et al. BMP9 and BMP10 are critical for postnatal retinal vascular remodeling. Blood 2012, 119:6162-6171.
135. Dahlqvist C., et al. Functional Notch signaling is required for BMP4-induced inhibition of myogenic differentiation. Development 2003, 130:6089-6099.
136. Larrivee B., et al. ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway. Dev. Cell 2012, 22:489-500.
137. Rochon E.R., Wright D.S., Schubert M.M., Roman B.L. Context-specific interactions between Notch and ALK1 cannot explain ALK1-associated arteriovenous malformations. Cardiovasc. Res. 2015, 107:143-152.
138. Woltje K., Jabs M., Fischer A. Serum induces transcription of Hey1 and Hey2 genes by Alk1 but not Notch signaling in endothelial cells. PLoS One 2015, 10.
139. Li F., et al. Endothelial Smad4 maintains cerebrovascular integrity by activating N-cadherin through cooperation with Notch. Dev. Cell 2011, 20:291-302.
140. Blokzijl A., et al. Cross-talk between the Notch and TGF-beta signaling pathways mediated by interaction of the Notch intracellular domain with Smad3. J. Cell Biol. 2003, 163:723-728.
141. Zhang K., et al. Hes1, an important gene for activation of hepatic stellate cells, is regulated by Notch1 and TGF-beta/BMP signaling. World J. Gastroenterol. 2015, 21:878-887.
142. Zavadil J., Cermak L., Soto-Nieves N., Bottinger E.P. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J. 2004, 23:1155-1165.
143. Ling F., Kang B., Sun X.H. Id proteins: small molecules, mighty regulators. Curr. Top. Dev. Biol. 2014, 110:189-216.
144. Bai G., et al. Id sustains Hes1 expression to inhibit precocious neurogenesis by releasing negative autoregulation of Hes1. Dev. Cell 2007, 13:283-297.
145. Song S., et al. Loss of TGF-beta adaptor beta2SP activates Notch signaling and SOX9 expression in esophageal adenocarcinoma. Cancer Res. 2013, 73:2159-2169.
146. Sun Y., et al. Notch4 intracellular domain binding to Smad3 and inhibition of the TGF-beta signaling. Oncogene 2005, 24:5365-5374.
147. Luna-Zurita L., et al. Integration of a Notch-dependent mesenchymal gene program and Bmp2-driven cell invasiveness regulates murine cardiac valve formation. J. Clin. Invest. 2010, 120:3493-3507.
148. Beets K., Huylebroeck D., Moya I.M., Umans L., Zwijsen A. Robustness in angiogenesis: Notch and BMP shaping waves. Trends Genet. 2013, 29:140-149.
149. Aspalter I.M., et al. Alk1 and Alk5 inhibition by Nrp1 controls vascular sprouting downstream of Notch. Nat. Commun. 2015, 6:7264.
150. Timmerman L.A., et al. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev. 2004, 18:99-115.
151. Mendelson J., et al. Dysfunctional transforming growth factor-beta signaling with constitutively active Notch signaling in Barrett's esophageal adenocarcinoma. Cancer 2011, 117:3691-3702.
152. Sjolund J., et al. The Notch and TGF-beta signaling pathways contribute to the aggressiveness of clear cell renal cell carcinoma. PLoS One 2011, 6.
153. Ohnuki H., et al. Tumor-infiltrating myeloid cells activate Dll4/Notch/TGF-beta signaling to drive malignant progression. Cancer Res. 2014, 74:2038-2049.
154. Xiao Z., et al. The Notch gamma-secretase inhibitor ameliorates kidney fibrosis via inhibition of TGF-beta/Smad2/3 signaling pathway activation. Int. J. Biochem. Cell Biol. 2014, 55:65-71.
155. Matsuno Y., Coelho A.L., Jarai G., Westwick J., Hogaboam C.M. Notch signaling mediates TGF-beta1-induced epithelial-mesenchymal transition through the induction of Snai1. Int. J. Biochem. Cell Biol. 2012, 44:776-789.
156. Hiratochi M., et al. The delta intracellular domain mediates TGF-beta/activin signaling through binding to Smads and has an important bi-directional function in the Notch-delta signaling pathway. Nucleic Acids Res. 2007, 35:912-922.
157. Dequeant M.L., Pourquie O. Segmental patterning of the vertebrate embryonic axis. Nat. Rev. Genet. 2008, 9:370-382.
158. Maroto M., Bone R.A., Dale J.K. Somitogenesis. Development 2012, 139:2453-2456.
159. Gibb S., Maroto M., Dale J.K. The segmentation clock mechanism moves up a Notch. Trends Cell Biol. 2010, 20:593-600.
160. Nakayama K., Satoh T., Igari A., Kageyama R., Nishida E. FGF induces oscillations of Hes1 expression and Ras/ERK activation. Curr. Biol. 2008, 18:R332-R334.
161. Hayashi S., et al. Sprouty4, an FGF inhibitor, displays cyclic gene expression under the control of the notch segmentation clock in the mouse PSM. PLoS One 2009, 4.
162. Munder S., et al. Notch signalling defines critical boundary during budding in Hydra. Dev. Biol. 2010, 344:331-345.
163. Osipo C., Golde T.E., Osborne B.A., Miele L.A. Off the beaten pathway: the complex cross talk between Notch and NF-kappaB. Lab. Investig. 2008, 88:11-17.
164. Guo S., Liu M., Gonzalez-Perez R.R. Role of Notch and its oncogenic signaling crosstalk in breast cancer. Biochim. Biophys. Acta 2011, 1815:197-213.
165. Bian Y., et al. An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J. Proteome 2014, 96:253-262.
166. Shiromizu T., et al. Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J. Proteome Res. 2013, 12:2414-2421.
167. Huttlin E.L., et al. A tissue-specific atlas of mouse protein phosphorylation and expression. Cell 2010, 143:1174-1189.
168. Cheng P., et al. Effects of Notch signaling on regulation of myeloid cell differentiation in cancer. Cancer Res. 2014, 74:141-152.
169. Bai Y., et al. Phosphoproteomics identifies driver tyrosine kinases in sarcoma cell lines and tumors. Cancer Res. 2012, 72:2501-2511.
170. Wagner S.A., et al. Proteomic analyses reveal divergent ubiquitylation site patterns in murine tissues. Mol. Cell. Proteomics 2012, 11:1578-1585.
171. Kim W., et al. Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol. Cell 2011, 44:325-340.
172. Sharma K., et al. Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Rep. 2014, 8:1583-1594.
173. Dephoure N., et al. A quantitative atlas of mitotic phosphorylation. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:10762-10767.
174. Phanstiel D.H., et al. Proteomic and phosphoproteomic comparison of human ES and iPS cells. Nat. Methods 2011, 8:821-827.
175. Franchin C., et al. Quantitative analysis of a phosphoproteome readily altered by the protein kinase CK2 inhibitor quinalizarin in HEK-293T cells. Biochim. Biophys. Acta 2015, 1854:609-623.
176. Malik R., et al. Quantitative analysis of the human spindle phosphoproteome at distinct mitotic stages. J. Proteome Res. 2009, 8:4553-4563.
177. Kettenbach A.N., et al. Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells. Sci. Signal. 2011, 4:rs5.
178. Hsu P.P., et al. The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 2011, 332:1317-1322.
179. Franz-Wachtel M., et al. Global detection of protein kinase D-dependent phosphorylation events in nocodazole-treated human cells. Mol. Cell. Proteomics 2012, 11:160-170.
180. Zhou H., et al. Toward a comprehensive characterization of a human cancer cell phosphoproteome. J. Proteome Res. 2013, 12:260-271.
181. Mayya V., et al. Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci. Signal. 2009, 2:ra46.
182. Beausoleil S.A., et al. Large-scale characterization of HeLa cell nuclear phosphoproteins. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:12130-12135.
183. Olsen J.V., et al. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006, 127:635-648.
184. Yu Y., et al. Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 2011, 332:1322-1326.
185. Yi T., et al. Quantitative phosphoproteomic analysis reveals system-wide signaling pathways downstream of SDF-1/CXCR4 in breast cancer stem cells. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:E2182-E2190.
186. Wagner S.A., et al. A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol. Cell. Proteomics 2011, 10. M111 013284.
187. Guo A., et al. Immunoaffinity enrichment and mass spectrometry analysis of protein methylation. Mol. Cell. Proteomics 2014, 13:372-387.